Kyushu University
Clinical trials sponsored by Kyushu University, explained in plain language.
-
New hope for kids with tough cancers: GAIA-102 trial begins
Disease control Recruiting nowThis early-stage trial tests a new drug, GAIA-102, in children whose neuroblastoma or other solid tumors have not responded to standard treatments. The study checks if GAIA-102 is safe when given alone or combined with other cancer drugs. About 61 children will take part to find …
Phase: PHASE1 • Sponsor: Kyushu University • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for Hard-to-Treat cancers: GAIA-102 targets belly fluid in stomach and pancreatic cancer
Disease control Recruiting nowThis study tests a new drug called GAIA-102, given alone or with another drug (pembrolizumab), for people with advanced stomach or pancreatic cancer that has spread to the belly lining and causes fluid buildup (malignant ascites). The first part checks safety and the best dose; t…
Phase: PHASE1, PHASE2 • Sponsor: Kyushu University • Aim: Disease control
Last updated May 13, 2026 16:01 UTC